Helen Heslop
Direktor/Vorstandsmitglied bei The Leukemia & Lymphoma Society, Inc.
Profil
Helen E.
Heslop is the founder of AlloVir, Inc. (founded in 2013) and Tikva Allocell Pte Ltd.
(founded in 2023).
Currently, Dr. Heslop holds the position of Director at The Leukemia & Lymphoma Society, Inc. since 2023.
Additionally, Dr. Heslop is a Director at the Center For Cell & Gene Therapy and Deputy Director at the Dan L.
Duncan Comprehensive Cancer Center.
Aktive Positionen von Helen Heslop
| Unternehmen | Position | Beginn |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Direktor/Vorstandsmitglied | 01.07.2023 |
| Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - |
| Center For Cell & Gene Therapy | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Helen Heslop
| Unternehmen | Position | Ende |
|---|---|---|
| ALLOVIR, INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
| Center For Cell & Gene Therapy | |
| Dan L. Duncan Comprehensive Cancer Center |
